Salix kept by Thomas Weisel at peer perform

Salix Pharmaceuticals Ltd. was maintained by Thomas Weisel Partners analyst Donald Ellis at a peer perform rating following second-quarter results. Salix shares Tuesday gained $1.48, or 7.61%, to close at $20.93 on volume of 2,074,960 shares versus the three-month running average of 450,598 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.